Montmorency Cherry Juice Significantly Lowers High Blood Pressure, Study Shows

635980417837304190cherrycover.jpg

05 May 2016 --- Drinking tart Montmorency cherry juice significantly reduces high blood pressure at a level comparable to that achieved by medication, according to new research from Northumbria University, Newcastle, UK.

The findings, which are published in The American Journal of Clinical Nutrition, found that men with early signs of hypertension – more commonly known as high blood pressure – saw a 7% reduction in blood pressure after drinking Montmorency cherry concentrate when compared to drinking a fruit-flavored cordial.
 
This reduction is comparable to the level achieved by anti-hypertensive medication.


High blood pressure affects over five million people in England and, if left untreated, increases risk of heart attack, heart failure, kidney disease, stroke or dementia. Normal blood pressure is around 120/80 mmHg.
 
Researchers from Northumbria University’s Department of Sport, Exercise and Rehabilitation worked with fifteen non-smoking participants who were displaying early hypertension with blood pressure readings of at least 130/90 mmHg, meaning they were at higher risk of experiencing cardiovascular related problems.
 
They were told that the study was to investigate the effect of a fruit juice on vascular function and were given either 60ml of a Montmorency cherry concentrate or the same amount of a commercially available fruit-flavored cordial.
 
Blood pressure and blood samples were taken before the cherry concentrate was consumed, and blood pressure was measured on an hourly basis thereafter. Blood samples and a series of other cardiovascular screening tests were taken again on a regular basis over the following eight hours.
 
The researchers found that the participants who were given the cherry concentrate saw a peak reduction in their blood pressure of 7 mmHg in the three hours after consuming the drink.
 
Past studies have shown that a reduction of between 5-6 mmHg over a sustained period has been associated with a 38% reduced risk of stroke and 23% reduced risk of coronary heart disease.
 
Interestingly, those participants with blood pressure levels at the higher end of the scale saw the most benefit.
 
The greatest improvement in systolic blood pressure occurred when the phenolic acids, protocatechuic and vanillic, within the cherry concentrate reached their peak levels in the plasma. The researchers believe that these particular compounds are, at least in part, responsible for the reduction.
 
Lead author and Lecturer in Sport and Exercise Nutrition, Karen Keane, explained: “The majority of cardiovascular disease is caused by risk factors that can be controlled, treated or modified, such as high blood pressure, cholesterol, obesity, tobacco use, lack of physical activity and diabetes. Raised blood pressure is the leading cause of deaths from cardiovascular disease, yet relatively small reductions in blood pressure can have a large impact on mortality rates.
 
“The magnitude of the blood pressure lowering effects we observed was comparable to those achieved by a single anti-hypertensive drug and highlights the potential importance that Montmorency cherries could have in the effective management of high blood pressure.”
 
Professor Glyn Howatson, research leader and Professor in Human and Applied Physiology, added: “This is the first study to investigate the acute effects of Montmorency tart cherry consumption on blood pressure, arterial stiffness and microvascular vasodilation in males with early hypertension. This exciting set of data complements a growing body of research to show that eating the right sorts of foods can provide potential health benefits.
 
“We believe these benefits might be linked to the combined actions of some of the plant compounds within the Montmorency concentrate and the positive impact they exert on vascular function.”
 
In recent years Northumbria University has undertaken a number of studies into the health benefits of tart Montmorency cherry concentrate. Their researchers have found that drinking the concentrate improves the quality and quantity of sleep. It also significantly reduces the symptoms associated with the painful condition of gout and enhances the recovery of muscle function after intense exercise, probably thanks to its anti-inflammatory and anti-oxidative properties.

To contact our editorial team please email us at editorial@cnsmedia.com

Related Articles

Nutrition & Health News

Athletic endurance improved with Beneo's low glycemic carb, study finds

24 May 2018 --- Athletes who consumed a drink containing the functional carbohydrate, Palatinose, before exercise exhibited improved cycling performance, a study at the University of Freiburg has found. This was in comparison with participants who were given maltodextrin, a high glycemic carbohydrate, before exercising. The study's findings could hold potential for the use of Palatinose as a sports nutrition ingredient.

Nutrition & Health News

US FDA takes action against OTC benzocaine products for teething infants

24 May 2018 --- The US Food and Drug Administration (FDA) has warned that over-the-counter (OTC) teething products containing benzocaine may pose a serious risk to infants and children. The popular numbing agent can offer temporary relief to sore gums in teething infants; however, the FDA advises that companies stop marketing and selling these products for use. The agency is also raising awareness of the risks that, they state, come with other oral health benzocaine products. 

Nutrition & Health News

UK sugar reduction efforts fail to reach initial target, industry urged to step up or face tax

23 May 2018 --- The first assessment of the UK government’s sugar reduction program has unveiled failings by industry to reduce sugar in the first year by 5 percent, leading to calls of a sugar tax on sweet treats. The results of the first year have been roundly criticized in the media and described as “hugely disappointing” after Public Health England data revealed that sugar was cut in some categories – sweet spreads and sauces, yogurts and fromage frais and breakfast cereals – while other food groups have fallen short.

Nutrition & Health News

Top companies reflect mixed progress on commitment to global nutrition, ranking shows

23 May 2018 --- Nestlé has nabbed the highest ranking spot in the 2018 Access to Nutrition Index (ATNI), reflecting its overall performance in nutrition-related commitments. Meanwhile, FrieslandCampina has improved the most since 2016, climbing four places in the ranking largely thanks to a new strategy to tackle under-nutrition and more responsible marketing commitments. However, the ATNI state that many companies are still doing too little in the realm of nutrition. The ATNI is the third Global Index that ranks the world’s 22 largest food and beverage companies on their contributions to addressing the twin global nutrition challenges of overweight and diet-related diseases and under-nutrition. 

Nutrition & Health News

Marealis’ novel shrimp peptide gains EFSA green light

22 May 2018 --- The European Food Safety Authority (EFSA) has approved an application for the novel food status of a shrimp peptide concentrate, meaning that the ingredient can now be utilized in EU supplement applications. The application was made by the company Medfiles Ltd. on behalf of Marealis, a developer of science-backed nutraceuticals. The supplements will be marketed to those who want to address the problem of prehypertension in the Marealis product, PreCardix.

More Articles
URL : http://www.nutritioninsight.com:80/news/montmorency-cherry-juice-significantly-lowers-high-blood-pressure-study-shows.html